Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JAI
|
||||
Former ID |
DIB016871
|
||||
Drug Name |
NSC-639829
|
||||
Synonyms |
N-[4-(5-Bromo-2-pyrimidinyloxy)-3-methylphenyl]-N'-[2-(dimethylamino)benzoyl]urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [544019] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H20BrN5O3
|
||||
Canonical SMILES |
CC1=C(C=CC(=C1)NC(=O)NC(=O)C2=CC=CC=C2N(C)C)OC3=NC=C(C=<br />N3)Br
|
||||
InChI |
1S/C21H20BrN5O3/c1-13-10-15(8-9-18(13)30-21-23-11-14(22)12-24-21)25-20(29)26-19(28)16-6-4-5-7-17(16)27(2)3/h4-12H,1-3H3,(H2,25,26,28,29)
|
||||
InChIKey |
JNGQUJZDVFZPEN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | [526117], [551871] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.